S |
2018-09-17 15:45:22.0 |
Adaptimmune Therapeutics PLC |
ADAP |
New Enterprise Associates 14 |
5.44% |
view |
S |
2018-02-02 16:48:04.0 |
Adaptimmune Therapeutics PLC |
ADAP |
Laing Ian Michael |
5.17% |
view |
S |
2018-01-29 15:44:32.0 |
Adaptimmune Therapeutics PLC |
ADAP |
New Enterprise Associates 14 |
6.56% |
view |
S |
2017-09-11 08:00:19.0 |
Adaptimmune Therapeutics PLC |
ADAP |
New Enterprise Associates 14 |
2.05% |
view |
B |
2017-02-03 17:01:01.0 |
Adaptimmune Therapeutics PLC |
ADAP |
Cross Nicholas John |
6.9% |
view |
B |
2017-02-03 17:00:31.0 |
Adaptimmune Therapeutics PLC |
n/a |
Immunocore Ltd |
6.4% |
view |
B |
2016-03-25 08:50:30.0 |
Adaptimmune Therapeutics PLC |
n/a |
Cross Nicholas John |
6.88% |
view |
B |
2016-03-25 08:49:37.0 |
Adaptimmune Therapeutics PLC |
n/a |
FMR LLC |
9.313% |
view |
B |
2016-02-10 15:45:36.0 |
Adaptimmune Therapeutics PLC |
n/a |
ORBIMED ADVISORS LLC |
6.6% |
view |
B |
2015-05-15 14:40:10.0 |
Adaptimmune Therapeutics PLC |
n/a |
FMR LLC |
6.017% |
view |